Division of Pulmonary, Critical Care, and Sleep Medicine, University of California Davis Medical Center, 4150 V Street, Sacramento, CA 95817, USA.
Clin Rev Allergy Immunol. 2012 Aug;43(1-2):14-29. doi: 10.1007/s12016-011-8273-z.
Asthma is a highly prevalent disease that presents commonly to the emergency department (ED) in acute exacerbation. Recent asthma treatment guidelines have added content dedicated to the management of acute exacerbations. Effective management of an exacerbation requires rapid assessment of severity through physical examination, measurement of peak expiratory flow rate, and response to initial treatment. Most therapies are directed at alleviating bronchospasm and decreasing airway inflammation. While inhaled short-acting beta-agonists, systemic corticosteroids, and supplemental oxygen are the initial and often only therapies required for patients with mild moderate exacerbations, high-dose beta agonists and inhaled anti-cholinergics should also be given to patients with severe exacerbations. Adjunctive therapy with intravenous magnesium and Heliox-driven nebulization of bronchodilators should be considered for patients presenting with severe and very severe exacerbations. Early recognition and appropriate management of respiratory failure are required to mitigate the risk of complications including death. Disposition should be determined based on serial assessments of the response to therapy over the first 4 h in the ED. Patients stable for discharge should receive medications, asthma education including a written asthma action plan, and should have follow-up scheduled for them by ED staff. Rapid implementation of evidence-based, multi-disciplinary care is required to ensure the best possible outcomes for this potentially treatable disease.
哮喘是一种高发疾病,常在急诊科(ED)急性发作时就诊。最近的哮喘治疗指南增加了专门针对急性发作管理的内容。有效管理急性发作需要通过体检、测量峰值呼气流速和对初始治疗的反应来快速评估严重程度。大多数治疗方法旨在缓解支气管痉挛和减少气道炎症。虽然吸入短效β-激动剂、全身皮质类固醇和补充氧气是轻度至中度发作患者的初始且通常唯一需要的治疗方法,但对于重度发作患者,还应给予高剂量β激动剂和吸入抗胆碱能药物。对于出现重度和极重度发作的患者,应考虑使用静脉镁和 Heliox 驱动的支气管扩张剂雾化作为辅助治疗。需要早期识别和适当处理呼吸衰竭,以降低包括死亡在内的并发症风险。应根据 ED 中治疗后 4 小时内的反应进行连续评估来确定处置。对于可出院的稳定患者,应给予药物、哮喘教育(包括书面哮喘行动计划),并由 ED 工作人员为其安排随访。需要快速实施基于证据的多学科护理,以确保这种潜在可治疗疾病的最佳结果。